Tetra Technologies Inc. Common Stock (TTI) : juste valeur

Thèse ACCE

Tetra Technologies sells completion fluids, calcium chloride and bromide brines used to control pressure in oil and gas wells, plus water treatment and produced-water services for the same customers. The thesis rests on its Completion Fluids and Products business, where it is one of a few suppliers with the solids and chemistry needed for high-pressure, high-temperature wells, a niche that tends to hold pricing better than commodity oilfield services. The near-term driver is margin repair after a year of weak trailing earnings: revenue is growing 6.8% and operating margin is 10.8% on a 29.6% gross margin, while the forward P/E of 12.7 sits far below the trailing 106.2, which implies the market expects earnings to recover sharply from a depressed base. The stock screens poorly on our score of 38/100, and trailing return on equity of 2.1% shows how little the business is earning on its capital today, so the case depends on that forward earnings recovery actually arriving. A deeper look should start with whether Completion Fluids volumes and pricing are reaccelerating, and whether the water business is earning its keep.